Cargando…
The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma
BACKGROUND: There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358902/ https://www.ncbi.nlm.nih.gov/pubmed/25890009 http://dx.doi.org/10.1186/s12957-015-0464-2 |
_version_ | 1782361305434292224 |
---|---|
author | Yan, Long Xie, Feng Yang, Cheng Yu, Lihan Zheng, Tao Fu, Jun Yang, Jiamei |
author_facet | Yan, Long Xie, Feng Yang, Cheng Yu, Lihan Zheng, Tao Fu, Jun Yang, Jiamei |
author_sort | Yan, Long |
collection | PubMed |
description | BACKGROUND: There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we did this retrospective study. METHODS: We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern Hepatobiliary Surgery Hospital in China. Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in the same period were also reviewed to make a comparison. In order to find out the definite survival information of SCC and ASC patients, 30 previous studies containing 37 primary hepatic SCC (16) and ASC (21) patients were reviewed, and their information of survival was analyzed together with the included patients in our hospital. RESULTS: Serum tumor markers showed significant differences between primary hepatic SCC/ASC and HCC patients, especially for serum alpha fetal protein (AFP) level and carbohydrate antigen 19-9 (CA 19-9). On the pathologic performance, primary SCC/ASC tumor was rarely accompanied with tumor capsule. They presented peripheral hepatic lymph node metastasis more likely and showed low proportion of microvascular invasion. The median survival time of primary hepatic SCC/ASC patients after liver resection (LR) was 15 months. And the 1-, 3-, 5-year survival rates after LR were 60%, 24%, and 12%, respectively. Significant difference was not discovered when SCC and ASC patients were compared with HCC patients (P = 0.294). The median survival time after LR for primary SCC and ASC patients was respectively 23 months and 13 months. CONCLUSIONS: The comprehensive application of some clinical characteristics, histopathologic features, and imaging findings may be useful for us in making definite diagnoses for primary hepatic SCC and ASC patients preoperatively. And the treatment of liver resection was effective for those patients who met the selection criteria for liver resection. |
format | Online Article Text |
id | pubmed-4358902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43589022015-03-14 The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma Yan, Long Xie, Feng Yang, Cheng Yu, Lihan Zheng, Tao Fu, Jun Yang, Jiamei World J Surg Oncol Research BACKGROUND: There are still several controversies and ambiguities in the aspects of primary hepatic squamous cell carcinoma and primary hepatic adenosquamous carcinoma. To further clarify the specific features of these two infrequent diseases and provide beneficial propose for clinical decision, we did this retrospective study. METHODS: We reviewed the clinical features and outcomes of three primary hepatic squamous cell carcinoma (SCC) patients and six primary hepatic adenosquamous carcinoma (ASC) patients from January 1998 to December 2011 in Eastern Hepatobiliary Surgery Hospital in China. Meanwhile, 40 hepatocellular carcinoma (HCC) patients and 26 metastatic hepatic SCC or ASC patients who were hospitalized in the same period were also reviewed to make a comparison. In order to find out the definite survival information of SCC and ASC patients, 30 previous studies containing 37 primary hepatic SCC (16) and ASC (21) patients were reviewed, and their information of survival was analyzed together with the included patients in our hospital. RESULTS: Serum tumor markers showed significant differences between primary hepatic SCC/ASC and HCC patients, especially for serum alpha fetal protein (AFP) level and carbohydrate antigen 19-9 (CA 19-9). On the pathologic performance, primary SCC/ASC tumor was rarely accompanied with tumor capsule. They presented peripheral hepatic lymph node metastasis more likely and showed low proportion of microvascular invasion. The median survival time of primary hepatic SCC/ASC patients after liver resection (LR) was 15 months. And the 1-, 3-, 5-year survival rates after LR were 60%, 24%, and 12%, respectively. Significant difference was not discovered when SCC and ASC patients were compared with HCC patients (P = 0.294). The median survival time after LR for primary SCC and ASC patients was respectively 23 months and 13 months. CONCLUSIONS: The comprehensive application of some clinical characteristics, histopathologic features, and imaging findings may be useful for us in making definite diagnoses for primary hepatic SCC and ASC patients preoperatively. And the treatment of liver resection was effective for those patients who met the selection criteria for liver resection. BioMed Central 2015-02-28 /pmc/articles/PMC4358902/ /pubmed/25890009 http://dx.doi.org/10.1186/s12957-015-0464-2 Text en © Yan et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Yan, Long Xie, Feng Yang, Cheng Yu, Lihan Zheng, Tao Fu, Jun Yang, Jiamei The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
title | The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
title_full | The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
title_fullStr | The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
title_full_unstemmed | The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
title_short | The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
title_sort | comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358902/ https://www.ncbi.nlm.nih.gov/pubmed/25890009 http://dx.doi.org/10.1186/s12957-015-0464-2 |
work_keys_str_mv | AT yanlong thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT xiefeng thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yangcheng thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yulihan thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT zhengtao thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT fujun thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yangjiamei thecomparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yanlong comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT xiefeng comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yangcheng comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yulihan comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT zhengtao comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT fujun comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma AT yangjiamei comparisonofsurgicalpatientswithprimaryhepaticsquamouscellcarcinomaoradenosquamouscarcinomaandsurgicalpatientswithhepatocellularcarcinoma |